April 25th 2025
Phenomix will showcase new data on prediction of adverse events to GLP-1 RA therapy, a new obesity sub-phenotype, and approaches to improve surgical outcomes.
Diabetes: A Primer on New Drug Options
November 1st 2007Over the past 20 years, the treatment armamentarium for diabetes has greatly expanded: 8 different classes of non-insulin drugs and 8 different types of insulin are now available. The newer classes of agents include disaccharidase inhibitors, thiazolidinediones, meglitinides, glucagonlike peptide analogs, and dipeptidyl peptidase IV inhibitors.
A Judgment on Heart Benefits of Best-Selling Diets
October 1st 2007WORCESTER, Mass. -- In a collision of the best-selling weight-loss books, the neovegetarian fare pushed by the Ornish diet earned heart-healthy honors, according to the standards of an index that dices the risks of fats and carbohydrates.